New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Living with obstructive lung disease is challenging, and managing day-to-day activities can be overwhelming. PIP can provide ...

Around 15,000 Kiwis living with chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in NZ, could benefit from the funding of a new medicine that will allow them to switch ...

Anyone who has worked in a coal mine is entitled to free black lung testing without a referral, but those who handle coal ...

The Australia-wide ZERO Childhood Cancer program now offers genetic testing for all children diagnosed with cancer as part of ...

Breathlessness is more common in people who already have respiratory or cardiovascular diseases, such as asthma ... It is essential to recognize if dyspnea is due to heart or lung problems in order to ...

A panel of experts, including Dr Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung ...

Repeat bronchoscopy in patients with suspected pulmonary diseases is safe, with a high diagnostic yield and low complication rate.

The FDA has approved Rybrevant plus chemotherapy in certain patients with locally advanced or metastatic non-small cell lung ...

Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of lung cancer cases. The treatment plan and goal of treatment depend on the stage of your NSCLC ...